Skip to main content

Birth Defect clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for
  • Hydrops: Diagnosing & Redefining Outcomes With Precision Study

    open to eligible people ages 18-55

    This is a multi-center, prospective study designed to investigate the genetic etiologies of non-immune hydrops fetalis (NIHF) and other birth defects. In the setting of NIHF, at least half of prenatally diagnosed cases remain of unknown etiology after standard work up, and a substantial proportion of other birth defects remain of unknown etiology as well. The investigators are performing trio exome sequencing (ES) for the fetus or neonate (meaning that samples are collected from the fetus or neonate as well each each biological parent for reference) to investigate the underlying genetic etiology.

    at UCSF

  • Clinical Utility of Pediatric Whole Exome Sequencing

    Sorry, in progress, not accepting new patients

    The investigator aims to examine the clinical utility of WES, including assessment of a variety of clinical outcomes in undiagnosed pediatric cases.

    at UCSF

Last updated: